TipRanks
Crescent Biopharma (DE:C68)
FRANKFURT:C68
Germany Market
C68
Crescent Biopharma
RESEARCH TOOLSreports

Crescent Biopharma (C68) Income Statement

2 Followers

Crescent Biopharma Income Statement

Last quarter (Q2 2026), Crescent Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Crescent Biopharma's net income was $-22.69M. See Crescent Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 10.84M$ 0.00$ 10.00K$ 75.00K$ 1.16M
Gross Profit
$ 10.84M$ 0.00$ 10.00K$ 75.00K$ 1.16M
Operating Expenses
$ 163.48M$ 49.90M$ 39.29M$ 47.48M$ 64.61M
Depreciation and Amortization
$ 84.00K$ 35.17K$ 153.30K$ 207.15K$ 264.60K
EBITDA
$ -149.67M$ -44.17M$ -39.12M$ -47.20M$ -63.18M
Operating Income
$ -152.63M$ -49.90M$ -39.28M$ -47.40M$ -63.45M
Other Income/Expenses
$ 690.00K$ 1.37M$ 2.38M$ 714.96K$ 19.77K
Pretax Income
$ -151.94M$ -48.52M$ -36.90M$ -46.69M$ -63.43M
Net Income
$ -153.94M$ -48.52M$ -36.90M$ -46.69M$ -63.43M
Per Share Metrics
Basic EPS
$ -14.78$ -63.22$ -58.25$ -88.88$ -123.27
Diluted EPS
$ -14.78$ -63.22$ -58.25$ -88.88$ -123.27
Weighted Average Shares Outstanding
 10.41M 767.58K 633.42K 525.31K 514.53K
Weighted Average Shares Outstanding (Diluted)
 10.41M 767.58K 633.42K 525.31K 514.53K
Currency in USD

Crescent Biopharma Earnings and Revenue History